Karunakaran Arun, Sumaya Wael, Gunn Julian P, Morton Allison C, Storey Robert F
Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
Hosp Pract (1995). 2012 Feb;40(1):224-31. doi: 10.3810/hp.2012.02.963.
Coronary heart disease is the leading cause of death worldwide. In the United States, approximately 1 of every 6 deaths in 2007 was caused by coronary heart disease. Clinical presentation in the acute setting is mostly due to atherosclerotic plaque rupture leading to flow limitation in the affected vessel, and myocardial ischemia and infarction. ST-segment elevation myocardial infarction is usually associated with complete occlusion of the coronary artery and carries the worst prognosis in terms of in-hospital mortality. Despite various advances in treatment options, including percutaneous coronary intervention, ischemic heart disease still carries a significant morbidity and mortality. In this article, we aim to provide a summary of a few key advances in the management of ST-segment elevation myocardial infarction.
冠心病是全球首要的死亡原因。在美国,2007年每6例死亡中约有1例由冠心病导致。急性情况下的临床表现主要是由于动脉粥样硬化斑块破裂,导致受累血管血流受限,进而引起心肌缺血和梗死。ST段抬高型心肌梗死通常与冠状动脉完全闭塞相关,就住院死亡率而言,其预后最差。尽管在治疗选择方面取得了各种进展,包括经皮冠状动脉介入治疗,但缺血性心脏病仍然具有较高的发病率和死亡率。在本文中,我们旨在总结ST段抬高型心肌梗死管理方面的一些关键进展。